Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 Marzo 2024 - 9:01PM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that its management team will present
at the 23rd Annual Needham Virtual Healthcare Conference on
Wednesday, April 10 at 1:30 p.m. Eastern Time.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable the selection of
targeted therapies based on ultra-comprehensive genomic profiling,
and enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240328562554/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Gen 2024 a Gen 2025
